EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieMultizentrische StudieOpen access

Smartphone App for Improving Self-Awareness of Adherence to Edoxaban Treatment in Patients With Atrial Fibrillation (ADHERE-App Trial): Randomized Controlled Trial

Minjae Yoon iD, Ji Hyun Lee iD, In-Cheol Kim iD, Ju-Hee Lee iD, Mi-Na Kim iD, Hack-Lyoung Kim iD, Sunki Lee iD, In Jai Kim iD, Seonghoon Choi iD, Sung-Ji Park iD, Taeho Hur iD, Musarrat Hussain iD and 2 more

Journal of Medical Internet Research · 2024-11-21 · 26 · e65010

DOI: 10.2196/65010 ↗

At a glance

Randomisierte kontrollierte Studie in Journal of Medical Internet Research, published online on 2024-11-21. Written by Minjae Yoon and 13 co-authors. Institution: Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, S…. Major MEDLINE topics: Atrial Fibrillation, Thiazoles, Smartphone, Pyridines. Cited 19 times so far (Crossref); 36 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Adherence to oral anticoagulant therapy is essential to prevent ischemic stroke in patients with atrial fibrillation (AF).

Objective

This study aimed to evaluate whether smartphone app–based interventions improve medication adherence in patients with AF.

Methods

This open-label, multicenter randomized controlled trial (ADHERE-App [Self-Awareness of Drug Adherence to Edoxaban Using an Automatic App Feedback System] study) enrolled patients with AF treated with edoxaban for stroke prevention. They were randomly assigned to app-conditioned feedback (intervention; n=248) and conventional treatment (control; n=250) groups. The intervention group received daily alerts via a smartphone app to take edoxaban and measure blood pressure and heart rate at specific times. The control group received only standard, guideline-recommended care. The primary end point was edoxaban adherence, measured by pill count at 3 or 6 months. Medication adherence and the proportion of adequate medication adherence, which was defined as ≥95% of continuous medication adherence, were evaluated.

Results

Medication adherence at 3 or 6 months was not significantly different between the intervention and control groups (median 98%, IQR 95%-100% vs median 98%, IQR 91%-100% at 3 months, P=.06; median 98%, IQR 94.5%-100% vs median 97.5%, IQR 92.8%-100% at 6 months, P=.15). However, the proportion of adequate medication adherence (≥95%) was significantly higher in the intervention group at both time points (76.8% vs 64.7% at 3 months, P=.01; 73.9% vs 61% at 6 months, P=.007). Among patients aged >65 years, the intervention group showed a higher medication adherence value and a higher proportion of adequate medication adherence (≥95%) at 6 months.

Conclusions

There was no difference in edoxaban adherence between the groups. However, the proportion of adequate medication adherence was higher in the intervention group, and the benefit of the smartphone app–based intervention on medication adherence was more pronounced among older patients than among younger patients. Given the low adherence to oral anticoagulants, especially among older adults, using a smartphone app may potentially improve medication adherence. Trial Registration International Clinical Trials Registry Platform KCT0004754; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=28496&search_page=L International Registered Report Identifier (IRRID) RR2-10.1136/bmjopen-2021-048777

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationThiazolesSmartphonePyridinesDrug MonitoringHumansMaleAgedFemaleMiddle AgedMobile ApplicationsAnticoagulantsFactor Xa Inhibitors

Author keywords

anticoagulantsatrial fibrillationdigital healthmedication adherencemobile appsmobile phone

Substances

edoxabanThiazolesPyridinesAnticoagulantsFactor Xa Inhibitors

Authors and institutions

  • Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
  • Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
  • Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
  • Department of Cardiology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Division of Cardiology, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Department of Cardiology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.

ORCID profiles: Minjae Yoon, Ji Hyun Lee, In-Cheol Kim, Ju-Hee Lee, Mi-Na Kim, Hack-Lyoung Kim, Sunki Lee, In Jai Kim, Seonghoon Choi, Sung-Ji Park, Taeho Hur, Musarrat Hussain, Sungyoung Lee, Dong-Ju Choi

Cite

APA

Yoon, M., Lee, J. H., Kim, I. C., Lee, J. H., Kim, M. N., Kim, H. L., Lee, S., Kim, I. J., Choi, S., Park, S. J., Hur, T., Hussain, M., Lee, S., & Choi, D. J. (2024). Smartphone App for Improving Self-Awareness of Adherence to Edoxaban Treatment in Patients With Atrial Fibrillation (ADHERE-App Trial): Randomized Controlled Trial. Journal of Medical Internet Research, 26, e65010. https://doi.org/10.2196/65010

Vancouver

Yoon M, Lee JH, Kim IC, Lee JH, Kim MN, Kim HL, et al. Smartphone App for Improving Self-Awareness of Adherence to Edoxaban Treatment in Patients With Atrial Fibrillation (ADHERE-App Trial): Randomized Controlled Trial. Journal of Medical Internet Research. 2024;26:e65010. doi:10.2196/65010

BibTeX
@article{Yoon2024,
  author = {Yoon, Minjae and Lee, Ji Hyun and Kim, In-Cheol and Lee, Ju-Hee and Kim, Mi-Na and Kim, Hack-Lyoung and Lee, Sunki and Kim, In Jai and Choi, Seonghoon and Park, Sung-Ji and Hur, Taeho and Hussain, Musarrat and Lee, Sungyoung and Choi, Dong-Ju},
  title = {Smartphone App for Improving Self-Awareness of Adherence to Edoxaban Treatment in Patients With Atrial Fibrillation (ADHERE-App Trial): Randomized Controlled Trial},
  journal = {Journal of Medical Internet Research},
  year = {2024},
  volume = {26},
  pages = {e65010},
  doi = {10.2196/65010}
}
Start for free →